New transplant recipe may tame severe anemia
NCT ID NCT06837987
First seen Jun 26, 2026 · Last updated Jun 26, 2026
Summary
This study reviews a modified transplant conditioning regimen for severe aplastic anemia in 72 patients across two hospitals. The approach uses a combination of fludarabine, melphalan, and cyclophosphamide to prepare the body for a stem cell transplant. Researchers looked at how well the transplant took and how many patients developed graft-versus-host disease, a common complication.
What this could mean
Our plain-language read of the trial. This is informational only — not medical advice or a prediction.
Active substance
modified transplantation conditioning (fludarabine, melphalan, cyclophosphamide)
What this could lead to
If successful, this modified transplant approach could offer a safer and more effective way to treat severe aplastic anemia, reducing complications like graft failure and graft-versus-host disease.
What could go wrong
This is a small, retrospective study with no control group, so results may not apply to all patients. Transplant procedures carry risks such as infection, organ damage, and graft failure.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for APLASTIC ANAEMIA are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
Department of Hematology，920th Hospital of Joint Logistics Support Force
Kunming, Yunnan, 650000, China